Genetic Marker and/or Biomarkers for Traumatic Brain Injury, and Ultrasensitive Assays for Biomarkers of Traumatic Brain Injury

Quick Links

Disclose Your Invention
MTA/CDA Assistance
Technologies for Licensing
Industry Collaboration Opportunities
Research and Clinical Trials
Education Links
Office of Sponsored Research

Categories:  “Neurological Disorders” “Diagnostics

Reference #: 2017-042

OTC Contact: Ruchika Nijhara, Ph.D., MBA, CLP (Directory Information | Send a Message)


This invention provides an ultrasensitive assay for GFAP and other biomarkers of TBI to accurately detect or measure biomarkers of mild, moderate and severe TBI. Further, it provides a means to monitor or prevent sequelae of TBI, helping to triage and guide the treatment of TBI afflicted individuals of varying severity.



Stage of Development


Patent Status

IP protected.


Mark Burns